Production and validation of the pharmacokinetics of a single-chain Fv fragment of the MGR6 antibody for targeting of tumors expressing HER-2
β Scribed by Fabio Turatti; Delia Mezzanzanica; Elena Nardini; Elena Luison; Lorenzo Maffioli; Emilio Bombardieri; Claudia de Lalla; Silvana Canevari; Mariangela Figini
- Publisher
- Springer-Verlag
- Year
- 2001
- Tongue
- English
- Weight
- 150 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Inherent and acquired multidrug resistance (MDR) is characterized by a simultaneous resistance to diverse anticancer drugs and is a major impediment towards curative chemotherapy of cancer. Hence one important goal is to develop strategies aimed at specific targeting of major anticancer
## Abstract We have generated two distinct recombinant bispecific antibody molecules for the retargeting of adenoviral vectors to CEAβexpressing tumour cells. These antibody molecules were produced by combining the antigenβbinding sites of a neutralising antiβfibre knob scFv (S11) and an antiβCEA a